is semaglutide or tirzepatide safer I compare two weight loss medications with my patients every single week. Here's what the data actually shows. (Ozempic/Wegovy) delivered a 13.7% average weight loss in clinical trials. That's significant. But 💉 Semaglutide vs. Tirzepatide —

At week 13, significant reductions versus placebo were observed in glycated hemoglobin (HbA1c: 0.87%), body weight (2.54%), systolic blood pressure (SBP: 3.84 mmHg), pulse pressure (3.81 mmHg), high-sensitivity C-reactive protein (hsCRP: 18.08%), and lipid parameters including total cholesterol (7.00%), nonHDL-C (8.02%), and triglycerides (8.15%)

With the participation of researchers from the Paul Langerhans Institute Dresden (PLID), partner at the German Center for Diabetes Research, a GLP-1 receptor agonist in the form of tablets could for the first time be compared with the most common second-line therapy of T2D, a DPP-IV inhibitor

Address the unprecedented demand for GLP-1 receptor agonists

The program offers three GLP-1 medication options: FDA-approved Wegovy and Zepbound, as well as compounded liraglutide, all with transparent pricing to address cost barriers

Retatrutide 20mg Pen is listed as part of the Aegis Peptides Retatrutide research product range

Glucagon-like Peptide 1 (7-37) GLP-1 - CAS 106612-94-6 is diabetes peptide for research use only